View all text of Chapter 93 [§ 8601 - § 8607]
§ 8607. Other matters of cooperation
(a) In general
(b) Development of health technologies
(1) In general
(2) Types of health technologies
(3) Restrictions on funding
(4) Option for establishing new program
Amounts appropriated pursuant to paragraph (1) may be expended for a bilateral program with the Government of Israel that—
(A) is in existence on the day before January 1, 2021, for the purposes described in paragraph (1); or
(B) is established after January 1, 2021, by the Secretary of Health and Human Services, in consultation with the Secretary of State, in accordance with the Agreement between the Government of the United States of America and the Government of the State of Israel on Cooperation in Science and Technology for Homeland Security Matters, done at Jerusalem May 29, 2008 (or a successor agreement), for the purposes described in paragraph (1).
(5) Public availability
(c) Coordinator of United States-Israel Research and Development
(1) In general
(2) Authorities and duties
(d) Office of Global Policy and Strategy of the Food and Drug Administration
(1) In general
(2) Report
Not later than one year after January 1, 2021, the Commissioner, acting through the head of the Office of Global Policy and Strategy, shall submit a report describing the benefits to the United States and to Israel of opening an office in Israel for the Office of Global Policy and Strategy to—
(A) the Committee on Foreign Relations of the Senate;
(B) the Committee on Health, Education, Labor, and Pensions of the Senate;
(C) the Committee on Foreign Affairs of the House of Representatives; and
(D) the Committee on Energy and Commerce of the House of Representatives.
(e) United States-Israel Energy Center
(f) United States-Israel Binational Industrial Research and Development Foundation
(g) Omitted
(h) Annual policy dialogue
(i) Cooperation on space exploration and science initiatives
(j) Research and development cooperation relating to desalination technology
Not later than one year after January 1, 2021, the Director of the Office of Science and Technology Policy shall submit a report that describes research and development cooperation with international partners, such as the State of Israel, in the area of desalination technology in accordance with section 9(b)(3) of the Water Desalination Act of 1996 (42 U.S.C. 10301 note) to—
(1) the Committee on Foreign Relations of the Senate;
(2) the Committee on Energy and Natural Resources of the Senate;
(3) the Committee on Foreign Affairs of the House of Representatives; and
(4) the Committee on Natural Resources of the House of Representatives.
(k) Research and treatment of posttraumatic stress disorder
(Pub. L. 116–283, div. A, title XII, § 1280A, Jan. 1, 2021, 134 Stat. 3982.)